{"id":631256,"date":"2022-12-19T20:44:01","date_gmt":"2022-12-19T20:44:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=631256"},"modified":"2022-12-19T20:44:01","modified_gmt":"2022-12-19T20:44:01","slug":"inview-analytics-joins-end-drug-shortages-alliance-providing-realtime-visibility","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/inview-analytics-joins-end-drug-shortages-alliance-providing-realtime-visibility_631256.html","title":{"rendered":"Inview Analytics Joins End Drug Shortages Alliance Providing Real-Time Visibility"},"content":{"rendered":"
\"Inview<\/a><\/div>\n
A data-sharing solution for drug shortages and pharmaceutical waste<\/div>\n

St. Petersburg, FL – December 19, 2022 –<\/strong> InView Analytics, Inc<\/a>, a Microsoft (NASD: MSFT) for startups company, is proud to announce that they have officially joined the End Drug Shortages Alliance. The End Drug Shortages Alliance is a collaboration of select health systems, supply chains, industry, and other stakeholders committed to resolving pharmaceutical supply challenges that impede access to essential medications in the United States.<\/p>\n

Established in 2022 by Vizient<\/a>, the End Drug Shortages Alliance (EDSA) is a coalition that consists of health care providers, manufacturers, group purchasing organizations, distributors and other industry stakeholders. The mission of the EDSA is to solve “pharmaceutical supply challenges by increasing transparency,” according to the EDSA’s website. The InView Analytics platform provides inventory transparency to quickly locate medications in short supply or generic alternatives that may be sitting on pharmacy shelves, connecting siloed healthcare systems to a centralized inventory hub and enabling pharmacists to proactively manage drug shortages. This allows pharmacies to adjust their inventory to meet local demand for critical drugs by creating a stock inventory that no single pharmacy can maintain.<\/p>\n

“We are extremely proud to join the ‘End Drug Shortages Alliance officially,” stated Dr. Alex Toth, RPh<\/a>, InView Analytics Co-Founder and owner of Plumsted Pharmacy. “It is a testament to exactly what we aim to achieve here at InView Analytics. Not only will this solve pharmacies micro-sourced supply challenges, but allow patients who desperately need their medications to locate those hard-to-find products at a community-based pharmacy. <\/p>\n

“InView is leveraging connected inventories to increase the availability of individual drugs. By joining the ‘End Drug Shortages Alliance,’ InView Analytics is taking a major step. They are working with other industry leaders to create a better system for patients who desperately need their medications.” remarked Paul Shelton<\/a>, President at PharmaComplete Consulting Services, in a statement.  <\/p>\n

About InView Analytics<\/strong><\/p>\n

InView is a purpose-driven healthcare technology company that drives value through its unique combination of connected inventory, collaboration, and micro-fulfillment distribution. The platform is designed to connect prescribers to pharmacies and pharmacies to patients. InView is committed to solving drug shortages, eliminating drug waste, and expanding healthcare. <\/p>\n

For more information on InView Analytics Inc, please visit Inviewanalytics.com<\/a>. <\/p>\n

Source: InView Analytics<\/p>\n

Media Contact:<\/p>\n

Thomas Mustac<\/p>\n

thomas.mustac@otterpr.com<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Otter PR<\/a>
Contact Person:<\/strong> Thomas Mustac
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 7274002578
Address:<\/strong>320 1st Ave N Suite 110
City:<\/strong> St. Petersburg
State:<\/strong> Florida
Country:<\/strong> United States
Website:<\/strong> OtterPR.com<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

A data-sharing solution for drug shortages and pharmaceutical waste St. Petersburg, FL – December 19, 2022 – InView Analytics, Inc, a Microsoft (NASD: MSFT) for startups company, is proud to announce that they have officially joined the End Drug Shortages … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,444,405,406,420],"tags":[],"class_list":["post-631256","post","type-post","status-publish","format-standard","hentry","category-Business","category-Government-Politics","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/631256","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=631256"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/631256\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=631256"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=631256"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=631256"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}